| |
| |
|
| Insider
Information: |
Orbimed Capital Ii Llc |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
2,531,143 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$26,619,183 |
|
|
| Total
Shares |
2,531,143 |
|
|
| Total
Value |
$26,619,183 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Avanir Pharmaceuticals |
AVNR |
Director |
2006-02-13 |
0 |
2006-05-31 |
1,706,137 |
Premium* |
|
|
Supernus Pharmaceuticals Inc |
SUPN |
10% Owner |
2012-12-17 |
0 |
2013-02-13 |
817,000 |
Premium* |
|
|
Acceleron Pharma Inc |
XLRN |
10% Owner |
|
0 |
2013-09-18 |
8,006 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XLRN |
Acceleron Pharma Inc |
10% Owner |
– – • |
2013-09-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
8,006 |
|
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
10% Owner |
– – • |
2013-02-13 |
4 |
S |
$7.58 |
$1,136,355 |
I/I |
(150,000) |
817,000 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
10% Owner |
– – • |
2013-02-12 |
4 |
S |
$7.52 |
$1,144,690 |
I/I |
(152,183) |
858,100 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
10% Owner |
– – • |
2012-12-18 |
4 |
S |
$7.08 |
$707,670 |
I/I |
(100,000) |
0 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
10% Owner |
– – • |
2012-12-17 |
4 |
S |
$6.85 |
$1,354,617 |
I/I |
(197,815) |
100,000 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2006-05-31 |
4/A |
D |
$9.79 |
$6,159,095 |
I/I |
(629,121) |
1,706,137 |
|
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2006-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
2,341,693 |
2,335,258 |
|
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
